|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
Back to Reuters Health News Archives
Reuters Health News: 10-09-2004
WASHINGTON (Reuters) - Anti-tobacco senators agreed late Friday to stop delaying a tax bill that includes a bailout for tobacco farmers and pass a separate bill calling for Food and Drug Administration regulation of tobacco, Sen. Edward Kennedy's office said late Friday.
WASHINGTON (Reuters) - U.S. regulators were trying to decide whether to allow the release of 48 million doses of Chiron Corp.'s flu vaccine when British authorities stepped in to block the company from shipping the vaccine, FDA officials said Friday.
NEW YORK (Reuters Health) - Previous research has established a moderate relationship between marijuana abuse and depressive disorders. Now researchers report that the association between marijuana use and major depression probably arises from a combination of shared genetic and environmental vulnerabilities.
NEW YORK (Reuters Health) - Norethindrone acetate (NETA), one of the hormones replacement drug Femhrt, protects the heart from damage, whereas medroxyprogesterone acetate (MPA), a hormone found in the drug Prempro, makes the heart more vulnerable to injury, according to findings from an animal study.
WASHINGTON (Reuters) - Concerned health officials began investigating what went wrong at a British vaccine plant where half the U.S. flu shots were made, while Americans jostled for now-scarce immunizations on Friday.
NEW YORK (Reuters Health) - Cramming in the recommended weekly amount of exercise into the weekend appears to offer some health benefits for otherwise healthy men, new research reports.
NEW YORK (Reuters Health) - The findings from a small study suggest that etanercept may be a useful treatment for the excessive daytime sleepiness that often occurs with obstructive sleep apnea. In fact, the decrease in sleepiness was greater than typically seen with continuous positive airway pressure, one of the standard treatments for this condition.
NEW YORK (Reuters Health) - The prevalence of the metabolic syndrome is increasing among U.S. adults, and will likely lead to increases in diabetes and heart disease, results of a study published in the October issue of Diabetes Care suggest.
NEW YORK (Reuters Health) - Pregnant women with serious gum disease appear to have an increased risk of delivering prematurely, but whether this condition actually triggers early labor remains unclear, according to a new study.
NEW YORK (Reuters) - Johnson & Johnson is warning doctors that patients taking its rheumatoid arthritis drug Remicade may have a higher risk of lymphoma, a blood cancer, the company said on Friday.
|
|